摘要
目的探究临床药师参与糖尿病规范治疗的管理运作模式效果及临床安全性分析。方法本研究选取2019年6月至2020年6月新疆生产建设兵团第五师医院接诊的100例糖尿病患者为研究对象,采用随机数字表法分为研究组(n=50)和常规组(n=50)。常规组患者给予常规医疗服务管理,研究组患者给予常规治疗管理联合临床医师参与糖尿病规范治疗管理,比较两组患者治疗前后药品种类和药品费用的情况、血糖指标、患者的服药依从性和对临床药师满意度、不良反应的发生情况。结果治疗后,研究组使用药品种类和药品费用低于常规组,差异有统计学意义(P<0.05);治疗后两组患者血糖指标均显著下降,且研究组患者血糖指标改善情况优于常规组,差异有统计学意义(P<0.05);研究组患者服药依从性为98.00%,显著高于常规组的84.00%(P<0.05);研究组对临床药师满意度为96.00%,高于常规组的76.00%,差异有统计学意义(P<0.05);研究组患者不良反应总发生率为4.00%,低于常规组的24.00%,差异有统计学意义(P<0.05)。结论糖尿病患者的治疗过程中,临床医师参与糖尿病规范治疗的管理,可以减少患者药物费用,提升患者临床治疗有效率,降低临床用药不良反应,安全性较高,值得临床推广应用。
Objective To investigate and analyze the effect of clinical pharmacists'involvement in the management operation mode of standardized diabetes treatment and the clinical safety.Methods A total of 100 cases of diabetic patients treated in Fifth Division Hospital of Xinjiang Production and Construction Corps,from June 2019 to June 2020 were selected for as the study subjects and randomly divided into the study group(n=50)and the conventional group(n=50)by the random number table method.The patients in the conventional group were given conventional medical service management,and the patients in the study group were given conventional treatment management combined with clinical pharmacists'involvement in the management of standardized diabetes treatment.The drug types and costs,blood glucose index,medication compliance,satisfaction with clinical pharmacists and the occurrence of adverse reactions before and after treatment were compared between the two groups.Results After treatment,the drug types and costs used in the study group were less/lower than those in the conventional group,with statistically significant difference(P<0.05).The blood glucose index of patients in both groups decreased significantly after treatment,and the improvement of blood glucose index in the study group was better than that in the conventional group,with statistically significant difference(P<0.05).The medication compliance of patients in the study group was 98.00%,which was significantly higher than that of 84.00%in the conventional group(P<0.05).The satisfaction with clinical pharmacists in the study group was 96.00%,which was significantly higher than that of 76.00%in the conventional group,with statistically significant difference(P<0.05).The total incidence of adverse reactions in the study group was 4.00%,which was significantly lower than that of 24.00%in the conventional group,with statistically significant difference(P<0.05).Conclusion In the treatment of diabetic patients,the involvement of clinical pharmacists in the management of standardized diabetes treatment can reduce the drug costs of patients,improve the effective rate of clinical treatment,reduce the adverse reactions of clinical medication and have higher safety,which is worthy of clinical promotion and applic ation.
作者
于鹏鑫
刘景春
吴晓晨
何全
蔡耿
YU Pengxin;LIU Jingchun;WU Xiaochen;HE Quan;CAI Geng(Department of Pharmacy,Fifth Division Hospital of Xinjiang Production and Construction Corps,Xinjiang,Bole 833400,China;Department of General Affairs,Fifth Division Hospital of Xinjiang Production and Construction Corps,Xinjiang,Bole 833400,China;Department of Medical Services,Fifth Division Hospital of Xinjiang Production and Construction Corps,Xinjiang,Bole 833400,China)
出处
《中国医药科学》
2021年第19期1-4,13,共5页
China Medicine And Pharmacy
基金
新疆生产建设兵团第五师双河市科技计划(2018SF001)。
关键词
临床药师
糖尿病
规范管理模式
血糖指标
安全性评价
Clinical pharmacists
Diabetes
Standardized management mode
B lood glucose index
Safety evaluation
